Report copyright - A Phase III trial of 5-FU/l-leucovorin/ irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer
Please pass captcha verification before submit form
Please pass captcha verification before submit form